Quick Answer
BioNexus Gene Lab Corp reported Earnings Per Share Diluted of $0.09 (loss) per share for the year ending 2024.
- BioNexus Gene Lab Corp showed an increase of +45.8% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from BioNexus Gene Lab Corp's annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2024: $0.09 (loss) per share | Fiscal year 2023: $0.17 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: